Sandoz sued over sterile solution

23-06-2017

Biopharmaceutical company Omeros has filed a complaint against Sandoz for allegedly infringing its patent covering Omidria (phenylephrine and ketorolac).


Sandoz, Omeros, patent, ANDA, FDA, District Court for the District of New Jersey

More on this story

Sandoz agrees to drop generic in Omeros clash
30-07-2018

LSIPR